drugset / Trial / NCT00231101
Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
RandomizedParallel-groupSingle-blindEct
Summary
A single-blind switching study in which forty subjects currently being treated with risperidone will be randomly assigned to either stay on risperidone or switched to quetiapine. Various behavioral and biological measures will be used to compare smoking behavior over time in these two groups.
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 800 mg | — |
Indications
No indication recorded.